United States · FDA National Drug Code directory
Cholestyramine for Oral Suspension
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62135-937_f1d8692b-deb3-d55f-e053-2a95a90ae615
- Product NDC
- 62135-937
- Form
- POWDER
- Composition / generic term
- Cholestyramine for Oral Suspension
- Labeler
- Chartwell RX, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19960815
- Source listing expiry
- 20261231
Source-listed ingredients
- CHOLESTYRAMINE — 4 g/5.7g
These values do not establish equivalence or a dose recommendation.
Packages
- 239.4 g in 1 CAN (62135-937-54) · 62135-937-54
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →